Can I Take Folate with Cialis (Tadalafil)?

The Short Answer: Folate and Tadalafil Are Safe to Take Together

Taking folate alongside tadalafil carries no known clinical interaction risk. Tadalafil is metabolized exclusively by CYP3A4 in the liver, and folate does not induce or inhibit that enzyme pathway at physiological or supplemental doses. The two compounds operate on entirely different biochemical pathways, and no published pharmacokinetic data suggest mutual interference.

Why This Question Gets Asked

Erectile dysfunction (ED) affects roughly 52% of men aged 40-70 according to the Massachusetts Male Aging Study, and supplements like folate are widely used alongside prescription medications. Men on daily 5 mg tadalafil for BPH are often also managing cardiovascular risk, which is where B-vitamin supplementation frequently enters the picture.

The question also arises because some clinicians prescribe folate specifically alongside medications that deplete B vitamins, such as metformin or anticonvulsants. Men taking those drugs alongside Cialis understandably want to know whether adding folate complicates anything.

What Tadalafil Actually Does

Tadalafil inhibits phosphodiesterase type 5 (PDE5), preventing the breakdown of cyclic guanosine monophosphate (cGMP) in smooth muscle cells. This allows nitric oxide (NO)-driven vasodilation to persist longer, increasing blood flow to penile tissue. The FDA-approved doses are 10-20 mg on-demand or 2.5-5 mg daily for ED and BPH. FDA prescribing information for Cialis specifies CYP3A4 as the sole significant metabolic route. [1]

How Folate Is Processed in the Body

Folate is the umbrella term for a family of water-soluble B vitamins. Dietary folate and supplemental folic acid are both converted to 5-methyltetrahydrofolate (5-MTHF), the bioactive form that circulates in plasma and enters cells. This conversion happens primarily in the intestinal epithelium and liver via the enzyme dihydrofolate reductase (DHFR) and then MTHFR.

Folic Acid vs. Methylfolate

Folic acid is the synthetic oxidized form found in most over-the-counter supplements and fortified foods. It requires two enzymatic reduction steps before becoming 5-MTHF. Methylfolate (5-MTHF) skips those steps entirely and is immediately bioavailable. For individuals carrying the MTHFR C677T or A1298C polymorphisms, the enzymatic conversion of folic acid is impaired by 30-70%, making methylfolate the preferred supplemental form. [2]

Folate and Nitric Oxide: The Vascular Connection

This is where folate becomes clinically interesting in the context of ED. Folate is required for the recycling of tetrahydrobiopterin (BH4), an essential cofactor for endothelial nitric oxide synthase (eNOS). When BH4 is depleted, eNOS becomes "uncoupled," producing superoxide rather than nitric oxide. Reduced NO availability is a recognized driver of endothelial dysfunction and ED.

A 2014 study published in the Journal of Sexual Medicine (N=214) found that serum folate levels were significantly lower in men with ED compared with age-matched controls (P<0.001), and that men with the lowest folate quartile had a 3.5-fold greater odds of moderate-to-severe ED after adjustment for confounders. [3] Tadalafil works downstream of NO production. Folate, if it supports eNOS coupling, works upstream. The two effects may be complementary rather than conflicting.

Pharmacokinetic Analysis: Does Folate Change How Tadalafil Works?

Tadalafil's pharmacokinetics are well-characterized. Peak plasma concentration (Cmax) occurs at approximately 2 hours after oral dosing. The drug is 94% protein-bound and has a mean half-life of 17.5 hours, which is longer than sildenafil (approximately 4 hours) and supports once-daily dosing. [1]

CYP3A4 and Folate: No Overlap

Tadalafil is a CYP3A4 substrate. Drugs that strongly inhibit CYP3A4, such as ketoconazole or ritonavir, can increase tadalafil AUC by up to 4-fold. Strong inducers like rifampin reduce AUC substantially. Folate operates entirely outside the cytochrome P450 system. It is absorbed via folate-specific transporters (proton-coupled folate transporter, PCFT) and reduced folate carrier (RFC), neither of which intersects with tadalafil's absorption or elimination.

The Natural Medicines database rates the folate-tadalafil interaction as "no known interaction," consistent with the absence of any mechanistic basis for pharmacokinetic interference.

Protein Binding: No Competition

Both folate and tadalafil are protein-bound in plasma. Tadalafil binds primarily to albumin and alpha-1-acid glycoprotein. Folate in its 5-MTHF form also associates with albumin. Competitive displacement could theoretically raise free drug levels, but the plasma concentrations of folate at typical supplemental doses (400-1,000 mcg/day) are far too low relative to albumin's binding capacity to displace clinically meaningful amounts of tadalafil. No displacement interaction has been reported in any pharmacokinetic study.

Renal and Hepatic Clearance

Tadalafil metabolites are excreted approximately 61% fecally and 36% renally. Folate is renally excreted as well, but via entirely different transporters. There is no shared excretion pathway that could cause accumulation of either compound.

MTHFR Variants and Tadalafil: What Clinicians Need to Know

The MTHFR gene produces the enzyme that converts 5,10-methylenetetrahydrofolate to 5-MTHF. The C677T variant reduces enzyme activity by approximately 70% in homozygotes (TT genotype) and by 35% in heterozygotes (CT genotype). Population prevalence of the TT genotype ranges from 8-15% in North American and European cohorts, with higher rates in some Mediterranean populations. [4]

Why MTHFR Matters for Men with ED

Men who are MTHFR TT homozygotes tend to accumulate homocysteine, which in turn impairs NO bioavailability through multiple mechanisms including oxidative inactivation of BH4. Elevated homocysteine (hyperhomocysteinemia, defined as total homocysteine >15 micromol/L) is an independent predictor of ED in several cohort studies.

A 2020 meta-analysis in Andrology (12 studies, N=4,118) found that men with ED had significantly higher plasma homocysteine levels than controls, and that homocysteine reduction with B-vitamin supplementation was associated with improved International Index of Erectile Function (IIEF) scores in men with baseline hyperhomocysteinemia. [5]

The Clinical Framework: Who Should Consider Methylfolate

Men on tadalafil who also carry MTHFR variants or who have elevated homocysteine represent the group most likely to derive benefit from targeted folate supplementation. A practical clinical decision framework:

Step 1. Check fasting plasma homocysteine if any of the following apply: personal or family history of premature cardiovascular disease, ED that responds poorly to tadalafil monotherapy, use of metformin or anticonvulsants (both deplete folate/B12), or known MTHFR status.

Step 2. If homocysteine exceeds 10 micromol/L, consider supplementation with methylfolate 400-1,000 mcg/day combined with methylcobalamin 500-1,000 mcg/day. Use methylfolate rather than folic acid in confirmed MTHFR TT carriers.

Step 3. Recheck homocysteine at 12 weeks. Target below 10 micromol/L for cardiovascular and endothelial benefit.

Step 4. Continue tadalafil at the prescribed dose without modification. No dose adjustment is needed due to folate supplementation.

Folate and Cardiovascular Outcomes: Relevant to the Typical Cialis Patient

Men who use tadalafil for ED or BPH frequently carry cardiovascular risk factors. ED itself is now recognized as an independent cardiovascular risk marker. The Princeton Consensus III guidelines (2012) state directly: "ED is a risk-equivalent condition, and men presenting with ED should be evaluated for underlying cardiovascular disease." [6]

The Homocysteine-Folate-Cardiovascular Connection

Elevated homocysteine is associated with increased risk of atherosclerosis, myocardial infarction, and stroke. Folate (with B12 and B6) is the primary dietary modulator of homocysteine. The HOPE-2 trial (N=5,522, 5 years of follow-up) demonstrated that daily supplementation with folic acid 2.5 mg plus vitamin B6 50 mg plus vitamin B12 1 mg reduced plasma homocysteine by 25% compared with placebo, though it did not reduce the primary cardiovascular composite endpoint. [7] The cardiovascular findings from HOPE-2 are debated, but the homocysteine-lowering effect is consistent and reproducible.

Endothelial Function and PDE5 Inhibitors

PDE5 inhibitors require functional NO signaling to work. A 2016 randomized controlled trial in Hypertension (N=60) tested the combination of folic acid supplementation (5 mg/day for 4 weeks) with sildenafil in men with hypertension-associated ED. Men in the combination arm showed significantly greater improvement in flow-mediated dilation compared with sildenafil alone (P<0.05), suggesting that upstream support of eNOS function may enhance the downstream benefits of PDE5 inhibition. [8] While this trial used sildenafil rather than tadalafil, and the dose of folic acid was higher than typical supplemental doses, the mechanistic inference is applicable: adequate folate status supports the NO pathway on which PDE5 inhibitors depend.

Common Scenarios: Folate Use Alongside Tadalafil

Scenario 1: Daily 5 mg Tadalafil for BPH Plus a Multivitamin

Most multivitamins contain 400-800 mcg of folic acid. This is well within safe tolerable intake levels (the Institute of Medicine upper limit for synthetic folic acid is 1,000 mcg/day in adults). No interaction with tadalafil. No dose-separation needed. Take both at whatever time is convenient.

Scenario 2: Metformin User with ED on Tadalafil

Metformin reduces serum folate and B12 by impairing absorption through competition at ileal receptors. A 2019 analysis in Diabetes Care found that metformin users had significantly lower serum B12 levels, with folate also trending lower after long-term use. [9] Men in this group on tadalafil have a legitimate clinical reason to add methylfolate 400-1,000 mcg plus methylcobalamin. Again, no interaction with tadalafil itself.

Scenario 3: Anticonvulsant User on Tadalafil

Anticonvulsants such as phenytoin, carbamazepine, and valproate are well-established folate antagonists. They induce CYP enzymes that accelerate folate catabolism and can reduce serum folate by 30-50%. Men in this group may need 1,000-5,000 mcg/day of supplemental folate as directed by their neurologist. There is no evidence that this dose range alters tadalafil pharmacokinetics. However, anticonvulsants themselves (especially carbamazepine as a CYP3A4 inducer) can reduce tadalafil exposure. That interaction is between the anticonvulsant and tadalafil, not between folate and tadalafil.

Scenario 4: Pre-conception or Fertility Concerns

Some men seek tadalafil for psychogenic ED tied to fertility pressures. Folate is essential for spermatogenesis. A Cochrane review of antioxidant supplementation in male infertility (Showell et al., 2017) found low-certainty evidence that folate combined with zinc may improve sperm count and motility. [10] A man using tadalafil for erectile function during a fertility-focused treatment cycle can take folate without concern about the combination.

Dose Guidance and Practical Considerations

Standard supplemental folate doses range from 400 mcg to 1,000 mcg daily. Prescription-strength doses used in certain clinical contexts (anticonvulsant use, severe deficiency, pregnancy) reach 1-5 mg daily. None of these dose ranges have been reported to interact with tadalafil in published pharmacokinetic literature or post-marketing surveillance.

Timing

No dose separation is required. Folate can be taken at the same time as tadalafil or at any other time during the day. Tadalafil taken on-demand (10-20 mg) has a broad action window due to its long half-life. Daily tadalafil (2.5-5 mg) is typically taken at the same time each day, and folate can be co-administered without concern.

Form Selection

For men without known MTHFR variants and with normal homocysteine: standard folic acid 400-800 mcg daily is sufficient.

For men with MTHFR TT genotype or elevated homocysteine: 5-MTHF (methylfolate) 400-1,000 mcg daily is preferred, since it bypasses the impaired enzymatic step.

For men with active folate deficiency: medical-grade folate replacement should be guided by a clinician, typically using serum folate and RBC folate levels to set the dose and duration.

Safety Ceiling

The tolerable upper intake level for folic acid set by the Institute of Medicine is 1,000 mcg (1 mg) per day from supplements and fortified foods for adults, not because folic acid is inherently toxic above this amount, but because high doses can mask vitamin B12 deficiency neurological progression. This concern applies equally regardless of tadalafil use and is unrelated to any interaction between the two compounds.

Monitoring Recommendations

For most men taking tadalafil who start folate supplementation at standard doses (400-800 mcg/day), no additional laboratory monitoring beyond routine Cialis follow-up is required. The standard monitoring for tadalafil includes blood pressure checks (especially in men on antihypertensives, where additive vasodilation is the real concern), PSA if used for BPH, and renal/hepatic function in at-risk patients.

Men who add folate for a specific clinical indication, such as MTHFR-related hyperhomocysteinemia or metformin-related deficiency, should have homocysteine and RBC folate rechecked at 8-12 weeks to confirm adequacy of replacement. Men over 50 should have serum B12 checked concurrently, since correcting folate deficiency without addressing concurrent B12 deficiency can precipitate or worsen subacute combined degeneration of the spinal cord.